相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIV-1 gp120 Determinants Proximal to the CD4 Binding Site Shift Protective Glycans That Are Targeted by Monoclonal Antibody 2G12
Maria J. Duenas-Decamp et al.
JOURNAL OF VIROLOGY (2010)
Profiles of Human Serum Antibody Responses Elicited by Three Leading HIV Vaccines Focusing on the Induction of Env-Specific Antibodies
Michael Vaine et al.
PLOS ONE (2010)
A Boost for HIV Vaccine Design
Dennis R. Burton et al.
SCIENCE (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Antibody responses elicited through homologous or heterologous prime-boost DNA and protein vaccinations differ in functional activity and avidity
Michael Vaine et al.
VACCINE (2010)
Determinants Flanking the CD4 Binding Loop Modulate Macrophage Tropism of Human Immunodeficiency Virus Type 1 R5 Envelopes
Maria Jose Duenas-Decamp et al.
JOURNAL OF VIROLOGY (2009)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid et al.
NATURE (2009)
Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Leonidas Stamatatos et al.
NATURE MEDICINE (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Improved induction of antibodies against key neutralizing epitopes by human immunodeficiency virus type 1 gp120 DNA prime-protein boost vaccination compared to gp120 protein-only vaccination
Michael Vaine et al.
JOURNAL OF VIROLOGY (2008)
Natural resistance of human immunodeficiency virus type 1 to the CD4bs antibody b12 conferred by a glycan and an arginine residue close to the CD4 binding loop
Maria Jose Duenas-Decamp et al.
JOURNAL OF VIROLOGY (2008)
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C
James M. Binley et al.
JOURNAL OF VIROLOGY (2008)
An HIV vaccine - Challenges and prospects
Margaret I. Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Variation in HIV-I R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors
Paul J. Peters et al.
RETROVIROLOGY (2008)
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers
Shixia Wang et al.
VACCINE (2008)
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses
Yun Li et al.
JOURNAL OF VIROLOGY (2008)
Duration of humoral immunity to common viral and vaccine antigens
Ian J. Amanna et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120
Emma T. Crooks et al.
VIROLOGY (2007)
Broad HIV-1 neutralization mediated by CD4-binding site antibodies
Yuxing Li et al.
NATURE MEDICINE (2007)
Extensively cross-reactive anti-HIV-1 neutralizing antibodies induced by gp140 immunization
Peng Fei Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
The HIV Env variant N283 enhances macrophage tropism and is associated with brain infection and dementia
Rebecca L. Dunfee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: Implications for transmission and pathogenesis
Paul J. Peters et al.
JOURNAL OF VIROLOGY (2006)
Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E
Shixia Wang et al.
VIROLOGY (2006)
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: Comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection
Nina R. Derby et al.
JOURNAL OF VIROLOGY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Enhanced immunogenicity of gp120 protein when combined with recombinant DNA priming to generate antibodies that neutralize the JR-FL primary isolate of human immunodeficiency virus type 1
SX Wang et al.
JOURNAL OF VIROLOGY (2005)
Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial
PB Gilbert et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages
PJ Peters et al.
JOURNAL OF VIROLOGY (2004)
分享论文
